S&P 500   4,977.40 (-0.67%)
DOW   37,962.62 (+0.50%)
QQQ   418.07 (-1.26%)
AAPL   165.21 (-1.10%)
MSFT   401.21 (-0.76%)
META   486.91 (-2.97%)
GOOGL   154.59 (-0.91%)
AMZN   175.51 (-2.07%)
TSLA   148.94 (-0.66%)
NVDA   804.39 (-5.00%)
AMD   149.63 (-3.51%)
NIO   3.84 (-4.00%)
BABA   68.98 (+0.15%)
T   16.42 (+0.55%)
F   12.14 (+0.66%)
MU   107.35 (-4.09%)
GE   149.95 (-1.96%)
CGC   8.16 (+4.21%)
DIS   112.41 (-0.02%)
AMC   3.25 (+11.30%)
PFE   25.85 (+1.81%)
PYPL   62.32 (+0.35%)
XOM   120.12 (+1.35%)
S&P 500   4,977.40 (-0.67%)
DOW   37,962.62 (+0.50%)
QQQ   418.07 (-1.26%)
AAPL   165.21 (-1.10%)
MSFT   401.21 (-0.76%)
META   486.91 (-2.97%)
GOOGL   154.59 (-0.91%)
AMZN   175.51 (-2.07%)
TSLA   148.94 (-0.66%)
NVDA   804.39 (-5.00%)
AMD   149.63 (-3.51%)
NIO   3.84 (-4.00%)
BABA   68.98 (+0.15%)
T   16.42 (+0.55%)
F   12.14 (+0.66%)
MU   107.35 (-4.09%)
GE   149.95 (-1.96%)
CGC   8.16 (+4.21%)
DIS   112.41 (-0.02%)
AMC   3.25 (+11.30%)
PFE   25.85 (+1.81%)
PYPL   62.32 (+0.35%)
XOM   120.12 (+1.35%)
S&P 500   4,977.40 (-0.67%)
DOW   37,962.62 (+0.50%)
QQQ   418.07 (-1.26%)
AAPL   165.21 (-1.10%)
MSFT   401.21 (-0.76%)
META   486.91 (-2.97%)
GOOGL   154.59 (-0.91%)
AMZN   175.51 (-2.07%)
TSLA   148.94 (-0.66%)
NVDA   804.39 (-5.00%)
AMD   149.63 (-3.51%)
NIO   3.84 (-4.00%)
BABA   68.98 (+0.15%)
T   16.42 (+0.55%)
F   12.14 (+0.66%)
MU   107.35 (-4.09%)
GE   149.95 (-1.96%)
CGC   8.16 (+4.21%)
DIS   112.41 (-0.02%)
AMC   3.25 (+11.30%)
PFE   25.85 (+1.81%)
PYPL   62.32 (+0.35%)
XOM   120.12 (+1.35%)
S&P 500   4,977.40 (-0.67%)
DOW   37,962.62 (+0.50%)
QQQ   418.07 (-1.26%)
AAPL   165.21 (-1.10%)
MSFT   401.21 (-0.76%)
META   486.91 (-2.97%)
GOOGL   154.59 (-0.91%)
AMZN   175.51 (-2.07%)
TSLA   148.94 (-0.66%)
NVDA   804.39 (-5.00%)
AMD   149.63 (-3.51%)
NIO   3.84 (-4.00%)
BABA   68.98 (+0.15%)
T   16.42 (+0.55%)
F   12.14 (+0.66%)
MU   107.35 (-4.09%)
GE   149.95 (-1.96%)
CGC   8.16 (+4.21%)
DIS   112.41 (-0.02%)
AMC   3.25 (+11.30%)
PFE   25.85 (+1.81%)
PYPL   62.32 (+0.35%)
XOM   120.12 (+1.35%)
OTCMKTS:AWKNF

Awakn Life Sciences (AWKNF) Stock Price, News & Analysis

$0.11
+0.01 (+9.67%)
(As of 04/18/2024 ET)
Today's Range
$0.11
$0.15
50-Day Range
$0.08
$0.16
52-Week Range
$0.04
$0.36
Volume
11,440 shs
Average Volume
20,321 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
AWKNF stock logo

About Awakn Life Sciences Stock (OTCMKTS:AWKNF)

Awakn Life Sciences Corp., a biotechnology company, engages in the researching, developing, operations, and delivering of psychedelic therapeutics to treat addiction and other mental health conditions in the United Kingdom and Europe. The company has a collaboration agreement with the University of Exeter for exploring the use of ketamine-assisted therapy to treat Severe AUD. Awakn Life Sciences Corp. is headquartered in Toronto, Canada.

AWKNF Stock Price History

AWKNF Stock News Headlines

The “Perfect Storm” for Gold
Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.
Joanna Goddard Loves a Smash and Grab
The “Perfect Storm” for Gold
Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.
Awakn Life Sciences Corp AWKNF
AWKNF Awakn Life Sciences Corp.
See More Headlines
Receive AWKNF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Awakn Life Sciences and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
Current Symbol
OTCMKTS:AWKNF
CIK
N/A
Phone
N/A
Fax
N/A
Employees
44
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
The 10 Best AI Stocks to Own in 2024 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

Key Executives

  • Mr. George Scorsis (Age 46)
    Co-founder & Chairman of the Board
  • Mr. Anthony Tennyson
    Co-founder, President, CEO & Director
  • Mr. Jonathan James Held C.A. (Age 38)
    CPA, CA, Interim CFO, Chief Business Officer & Secretary
    Comp: $109.58k
  • Prof. David John Nutt DM
    FMedSci, FRCP, FRCPsych, FSB, Ph.D., Chair of Pre-Clinical & Clinical Advisory Board and Chief Research Officer

AWKNF Stock Analysis - Frequently Asked Questions

How have AWKNF shares performed in 2024?

Awakn Life Sciences' stock was trading at $0.1012 on January 1st, 2024. Since then, AWKNF shares have increased by 12.1% and is now trading at $0.1134.
View the best growth stocks for 2024 here
.

Are investors shorting Awakn Life Sciences?

Awakn Life Sciences saw a drop in short interest in March. As of March 31st, there was short interest totaling 1,000 shares, a drop of 9.1% from the March 15th total of 1,100 shares. Based on an average trading volume of 15,900 shares, the days-to-cover ratio is presently 0.1 days.
View Awakn Life Sciences' Short Interest
.

How do I buy shares of Awakn Life Sciences?

Shares of AWKNF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:AWKNF) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners